Literature DB >> 17537849

Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease.

Shailesh K Choudhary1, Nienke Vrisekoop, Christine A Jansen, Sigrid A Otto, Hanneke Schuitemaker, Frank Miedema, David Camerini.   

Abstract

Long-term asymptomatic human immunodeficiency virus (HIV)-infected individuals (LTA) usually have low viral load and low immune activation. To discern whether viral load or immune activation is dominant in determining progression to AIDS, we studied three exceptional LTA with high viral loads. HIV type 1 isolates from these LTA were as pathogenic as viruses from progressors in organ culture. Despite high viral loads, these LTA had low levels of proliferating and activated T cells compared to progressors, like other LTA. In contrast to those in progressors, HIV-specific CD4(+) T-cell responses in these LTA were maintained. Thus, low immune activation despite a high viral load preserved HIV-specific T-cell responses and resulted in a long-term asymptomatic phenotype.

Entities:  

Mesh:

Year:  2007        PMID: 17537849      PMCID: PMC1951355          DOI: 10.1128/JVI.02663-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss.

Authors:  Mette D Hazenberg; Sigrid A Otto; Ferdinand W N M Wit; Joep M A Lange; Dörte Hamann; Frank Miedema
Journal:  AIDS       Date:  2002-06-14       Impact factor: 4.177

2.  Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors.

Authors:  Luca Meroni; Stefania Varchetta; Daniele Manganaro; Nadia Gatti; Agostino Riva; Antonella d'Arminio Monforte; Massimo Galli
Journal:  J Infect Dis       Date:  2002-07-01       Impact factor: 5.226

3.  Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection.

Authors:  Liselotte van Asten; Figen Danisman; Sigrid A Otto; José A M Borghans; Mette D Hazenberg; Roel A Coutinho; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2004-09-24       Impact factor: 4.177

4.  Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analyzed in a prospective cohort study.

Authors:  Christine A Jansen; Iris M De Cuyper; Berend Hooibrink; Akke K van der Bij; Debbie van Baarle; Frank Miedema
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

5.  Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users.

Authors:  J Carbone; J Gil; J M Benito; J Navarro; A Muñóz-Fernández; J Bartolomé; J M Zabay; F López; E Fernández-Cruz
Journal:  AIDS       Date:  2000-12-22       Impact factor: 4.177

6.  Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort.

Authors:  P Simmonds; D Beatson; R J Cuthbert; H Watson; B Reynolds; J F Peutherer; J V Parry; C A Ludlam; C M Steel
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

7.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

Authors:  Guido Silvestri; Donald L Sodora; Richard A Koup; Mirko Paiardini; Shawn P O'Neil; Harold M McClure; Silvija I Staprans; Mark B Feinberg
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

8.  Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.

Authors:  J V Giorgi; Z Liu; L E Hultin; W G Cumberland; K Hennessey; R Detels
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-08

9.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Authors:  Steven G Deeks; Christina M R Kitchen; Lea Liu; Hua Guo; Ron Gascon; Amy B Narváez; Peter Hunt; Jeffrey N Martin; James O Kahn; Jay Levy; Michael S McGrath; Frederick M Hecht
Journal:  Blood       Date:  2004-04-29       Impact factor: 22.113

10.  Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

Authors:  Mette D Hazenberg; Sigrid A Otto; Birgit H B van Benthem; Marijke Th L Roos; Roel A Coutinho; Joep M A Lange; Dörte Hamann; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

View more
  45 in total

1.  HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.

Authors:  Amie L Meditz; Michelle K Haas; Joy M Folkvord; Kelsey Melander; Russ Young; Martin McCarter; Samantha Mawhinney; Thomas B Campbell; Yolanda Lie; Eoin Coakley; David N Levy; Elizabeth Connick
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 2.  Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?

Authors:  A Saez-Cirion; B Jacquelin; F Barré-Sinoussi; M Müller-Trutwin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

Review 3.  Systems biology of natural simian immunodeficiency virus infections.

Authors:  Steven E Bosinger; Béatrice Jacquelin; Arndt Benecke; Guido Silvestri; Michaela Müller-Trutwin
Journal:  Curr Opin HIV AIDS       Date:  2012-01       Impact factor: 4.283

4.  Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation.

Authors:  Julia M Shaw; Peter W Hunt; J William Critchfield; Delandy H McConnell; Juan Carlos Garcia; Richard B Pollard; Ma Somsouk; Steven G Deeks; Barbara L Shacklett
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-16       Impact factor: 2.205

Review 5.  HIV-associated chronic immune activation.

Authors:  Mirko Paiardini; Michaela Müller-Trutwin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

6.  Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients.

Authors:  Heungsup Sung; You-Sun Jung; Young-Keol Cho
Journal:  Clin Vaccine Immunol       Date:  2009-06-17

7.  Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics.

Authors:  Ahmad R Sedaghat; Jennifer German; Tanya M Teslovich; Joseph Cofrancesco; Chunfa C Jie; C Conover Talbot; Robert F Siliciano
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

8.  CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland.

Authors:  Margaret May; Robin Wood; Landon Myer; Patrick Taffé; Andri Rauch; Manuel Battegay; Matthias Egger
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

9.  CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load.

Authors:  Adriana Andrade; Justin R Bailey; Jie Xu; Frances H Philp; Thomas C Quinn; Thomas M Williams; Stuart C Ray; David L Thomas; Joel N Blankson
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

10.  Host genetic determinants of HIV pathogenesis: an immunologic perspective.

Authors:  Peter W Hunt; Mary Carrington
Journal:  Curr Opin HIV AIDS       Date:  2008-05       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.